MAHs canvassed on drugs which might be withdrawn from the market

…OGYEI is determined to prevent problems arising from such situations, and that this is the reason for questioning MAHs with regard to their plans for products potentially threatened with withdrawal. As the next step, the authority will assess the possible impact of the anticipated changes.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.